MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0028942
Lewis Bioserch Pharma Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.94 Cr
▲ 19% YoY
Net profit · FY 2024
₹2.67 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹17.02 Lakh
EBITDA margin 3.4%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Open charges
₹1.4 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About Lewis Bioserch Pharma Private Limited
Data last updated:
Lewis Bioserch Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24100CH2012PTC033656. Its GSTIN is 04AACCL2249R1Z7 (Chandigarh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Deepak Thakral and Na Arti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 313 1st Floor Motor Market M Animajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.94 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹2.67 Lakh (net margin 0.5%) and EBITDA of ₹17.02 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
The company is associated with 2 brands: Medilewis Biotech and Lewis Bioserch Pharma. As per MCA filings, the company has open charges of ₹1.4 Cr on record.
Lewis Bioserch Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0028942). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lewisbioserchpharma.com.
Company Details of Lewis Bioserch Pharma Private Limited
CIN U24100CH2012PTC033656
Registration Number 033656
Incorporation Date 22 March 2012
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0028942
Key People
Deepak Thakral Director Na Arti Director Recognitions & Rankings of Lewis Bioserch Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressScf 313 1st Floor Motor Market M Animajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Lewis Bioserch Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Lewis Bioserch Pharma Private Limited
Lewis Bioserch Pharma operates two associated brands: Medilewis Biotech and Lewis Bioserch Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products including tablets, capsules, and injectables. | medilewisbiotech.com | |
| Manufactures and supplies tablets, capsules, syrups, and pharmaceutical services in India. | lewisbioserchpharma.com |
Business Activity of Lewis Bioserch Pharma Private Limited
The main business activity of Lewis Bioserch Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lewis Bioserch Pharma Private Limited FY 2025 filings available
Lewis Bioserch Pharma Private Limited reported revenue of ₹4.94 Cr (up 19% YoY) for FY 2024.
Revenue · FY 2024
₹4.94 Cr ▲ 19%
Net profit · FY 2024
₹2.67 Lakh margin 0.5%
EBITDA · FY 2024
₹17.02 Lakh margin 3.4%
Compounded Annual Growth Rate (CAGR) of Lewis Bioserch Pharma Private Limited
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 7%
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 19% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lewis Bioserch Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.02 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.67 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lewis Bioserch Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lewis Bioserch Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Lewis Bioserch Pharma Private Limited
Lewis Bioserch Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Thakral | Director | 22 Mar 2012 | 14 Years 6 Months | Current |
| Na Arti | Director | 21 Jan 2023 | 3 Years 9 Months | Current |
Peer Comparison of Lewis Bioserch Pharma Private Limited
Lewis Bioserch Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healall Pharmaceuticals Private Limited | ₹4.96 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Ludhiana, Punjab, India |
| NRJ Pharmachem Private Limited | ₹4.95 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Navi Mumbai, Maharashtra, India |
| Elikem Nutra Private Limited | ₹4.95 Cr (FY 2025) | •••• | •••• | 92.0% | •••• | Rakanpur, Gujarat, India |
| Gynofem Healthcare and Pharmaceuticals Limited | ₹4.94 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Indore, Madhya Pradesh, India |
| Uttranchal Pharmaceuticals Private Limited | ₹4.94 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Lewis Bioserch Pharma Private Limited this company | ₹4.94 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Chandigarh, India |
| Cataliq Laboratories Private Limited | ₹4.94 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Ahmedabad, Gujarat, India |
| Karlin Pharmaceuticals & Exports Private Limited | ₹4.93 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Chennai, Tamil Nadu, India |
| Xiocare Life Sciences Private Limited | ₹4.93 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Lucknow, Uttar Pradesh, India |
| Switzer Lifescience Private Limited | ₹4.93 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Ahmedabad, Gujarat, India |
| Reliv Healthcare Private Limited | ₹4.93 Cr (FY 2022) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Lewis Bioserch Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Lewis Bioserch Pharma Private Limited
Lewis Bioserch Pharma Private Limited is audited by AMIT K. SHARMA & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AMIT K. SHARMA & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Lewis Bioserch Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lewis Bioserch Pharma Private Limited
Open charges
₹1.4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2025 | Others | ₹90 Lakh | Open |
| 15 Jul 2023 | Hdfc Bank Limited | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Lewis Bioserch Pharma Private Limited
Employment history and EPFO contributions of people linked to Lewis Bioserch Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lewis Bioserch Pharma Private Limited
Lewis Bioserch Pharma Private Limited has 6 board changes on record since 2012: 2 appointments and 4 cessations. The latest: Na Arti was appointed as Director on 21 Jan 2023.
AGM
Lewis Bioserch Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 90.00 Lakh with Charge ID 101144787 was registered on 16 May 2025.
Filing
Lewis Bioserch Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100790091 was registered on 15 Jul 2023.
Appointed
Na Arti was appointed as Director.
Ceased
Rohtas Sharma ceased to be Director.
Ceased
Sunita ceased to be Director.
Ceased
Cheena Kapoor ceased to be Additional Director.
Ceased
Pankaj Kumar ceased to be Director.
Appointed
Deepak Thakral was appointed as Director.
Incorporation
22 Mar 2012
Lewis Bioserch Pharma Private Limited was registered on 22 Mar 2012 with Roc Chandigarh & aged 14 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Lewis Bioserch Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lewis Bioserch Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lewis Bioserch Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lewis Bioserch Pharma Private Limited
Lewis Bioserch Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AACCL2249R1Z7 | Chandigarh | Active | 01 Jul 2017 |
| 06AACCL2249R1Z3 | Haryana | Active | 20 Mar 2024 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lewis Bioserch Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lewis Bioserch Pharma Private Limited
Lewis Bioserch Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 2012 (14+ years old) and is registered under CIN U24100CH2012PTC033656.
Lewis Bioserch Pharma reported revenue of ₹4.94 Cr for FY 2024 (up 19% YoY).
Lewis Bioserch Pharma has 2 current directors:
- Deepak Thakral - Director
- Na Arti - Director
Lewis Bioserch Pharma reported a net profit of ₹2.67 Lakh (net margin 0.5%) and EBITDA of ₹17.02 Lakh (EBITDA margin 3.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lewis Bioserch Pharma is 11% over three years. In the latest year (FY 2024) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lewis Bioserch Pharma is 04AACCL2249R1Z7, registered in Chandigarh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AACCL2249R1Z3 (Haryana).
The CIN (Corporate Identification Number) of Lewis Bioserch Pharma is U24100CH2012PTC033656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lewis Bioserch Pharma was incorporated on 22 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Lewis Bioserch Pharma by revenue are Healall Pharmaceuticals Private Limited, NRJ Pharmachem Private Limited, Elikem Nutra Private Limited, Gynofem Healthcare and Pharmaceuticals Limited, Uttranchal Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Na Arti was appointed as Director on 21 Jan 2023. Rohtas Sharma ceased to be Director on 20 Jan 2023. Sunita ceased to be Director on 20 Jan 2023. Lewis Bioserch Pharma has 6 board changes on record in total.
Yes, Lewis Bioserch Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0028942).